Brief: Yumanity Therapeutics Posts Q2 Loss Per Share Of $1.03

Kineta

12/08/2021 22:06

Aug 12 (Reuters) - Yumanity Therapeutics Inc  YMTX.O :
    * YUMANITY THERAPEUTICS REPORTS SECOND QUARTER 2021
FINANCIAL
RESULTS AND RECENT CORPORATE DEVELOPMENTS
    * Q2 LOSS PER SHARE $1.03
    * Q2 EARNINGS PER SHARE ESTIMATE $-0.84 -- REFINITIV IBES
DATA
    * TOPLINE RESULTS FOR YTX-7739 PHASE 1B TRIAL IN PARKINSON'S
DISEASE PATIENTS EXPECTED FALL OF 2021
    * AS OF JUNE 30, 2021, CASH, CASH EQUIVALENTS AND
INVESTMENTS WAS
$55.6 MILLION

Source text for Eikon:  ID:nGNX9MDgG4 
Further company coverage:  YMTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))